
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies
Mark Horowitz, David Taylor
BJPsych Advances (2022) Vol. 28, Iss. 5, pp. 297-311
Open Access | Times Cited: 40
Mark Horowitz, David Taylor
BJPsych Advances (2022) Vol. 28, Iss. 5, pp. 297-311
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Prescribing in Older People
David G. Le Couteur, Sarah N. Hilmer, Nicholas Glasgow, et al.
(2025), pp. 627-712
Closed Access | Times Cited: 62
David G. Le Couteur, Sarah N. Hilmer, Nicholas Glasgow, et al.
(2025), pp. 627-712
Closed Access | Times Cited: 62
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 4
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 4
Machine learning based approaches for clinical and non-clinical depression recognition and depression relapse prediction using audiovisual and EEG modalities: A comprehensive review
Sana Yasin, Alice Othmani, Imran Raza, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106741-106741
Closed Access | Times Cited: 30
Sana Yasin, Alice Othmani, Imran Raza, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106741-106741
Closed Access | Times Cited: 30
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes
Christiaan H. Vinkers, Ralph Kupka, Brenda W.J.H. Penninx, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2575-2586
Open Access | Times Cited: 7
Christiaan H. Vinkers, Ralph Kupka, Brenda W.J.H. Penninx, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2575-2586
Open Access | Times Cited: 7
Designing withdrawal support services for antidepressant users: Patients’ views on existing services and what they really need
John Read, Joanna Moncrieff, Mark Horowitz
Journal of Psychiatric Research (2023) Vol. 161, pp. 298-306
Open Access | Times Cited: 14
John Read, Joanna Moncrieff, Mark Horowitz
Journal of Psychiatric Research (2023) Vol. 161, pp. 298-306
Open Access | Times Cited: 14
The Challenges Faced by Medical Personnel Misusing Drugs: A Phenomenological Study
Anita Fafa Dartey, Vivian Tackie, Ben Okon Inemesit, et al.
SAGE Open (2025) Vol. 15, Iss. 1
Open Access
Anita Fafa Dartey, Vivian Tackie, Ben Okon Inemesit, et al.
SAGE Open (2025) Vol. 15, Iss. 1
Open Access
Antidepressant prescribing in Australian primary care: time to reevaluate
Katharine Wallis, Anna King, Joanna Moncrieff
The Medical Journal of Australia (2025)
Open Access
Katharine Wallis, Anna King, Joanna Moncrieff
The Medical Journal of Australia (2025)
Open Access
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder
Andrea Fagiolini, Narcı́s Cardoner, Şebnem Pırıldar, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1715-1723
Open Access | Times Cited: 11
Andrea Fagiolini, Narcı́s Cardoner, Şebnem Pırıldar, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1715-1723
Open Access | Times Cited: 11
The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)
Joanna Moncrieff, John Read, Mark Horowitz
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100765-100765
Open Access | Times Cited: 4
Joanna Moncrieff, John Read, Mark Horowitz
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100765-100765
Open Access | Times Cited: 4
Social media group support for antidepressant deprescribing: a mixed-methods survey of patient experiences
Amy Coe, Noor Abid, Catherine Kaylor‐Hughes
Australian Journal of Primary Health (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 4
Amy Coe, Noor Abid, Catherine Kaylor‐Hughes
Australian Journal of Primary Health (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 4
Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms
Julia N. Stimpfl, John T. Walkup, Adelaide S. Robb, et al.
Journal of Child and Adolescent Psychopharmacology (2024)
Closed Access | Times Cited: 3
Julia N. Stimpfl, John T. Walkup, Adelaide S. Robb, et al.
Journal of Child and Adolescent Psychopharmacology (2024)
Closed Access | Times Cited: 3
Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review
Anders Sørensen, Karsten Juhl Jørgensen, Klaus Munkholm
Journal of Affective Disorders (2022) Vol. 316, pp. 177-186
Open Access | Times Cited: 14
Anders Sørensen, Karsten Juhl Jørgensen, Klaus Munkholm
Journal of Affective Disorders (2022) Vol. 316, pp. 177-186
Open Access | Times Cited: 14
The need for antidepressant withdrawal support services: Recommendations from 708 patients
John Read, Stevie Lewis, Mark Horowitz, et al.
Psychiatry Research (2023) Vol. 326, pp. 115303-115303
Open Access | Times Cited: 8
John Read, Stevie Lewis, Mark Horowitz, et al.
Psychiatry Research (2023) Vol. 326, pp. 115303-115303
Open Access | Times Cited: 8
Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population
Melanie A. Amrein, Michael P. Hengartner, Markus Näpflin, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 11, pp. 1505-1513
Open Access | Times Cited: 7
Melanie A. Amrein, Michael P. Hengartner, Markus Näpflin, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 11, pp. 1505-1513
Open Access | Times Cited: 7
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
Raqeeb Mahmood, Vuokko Wallace, Nicola Wiles, et al.
Health Expectations (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 2
Raqeeb Mahmood, Vuokko Wallace, Nicola Wiles, et al.
Health Expectations (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 2
Association between duration of antidepressant treatment for major depressive disorder and relapse rate after discontinuation: A meta-analysis
Yuhua Hu, Hui Xue, Xiaoyan Ni, et al.
Psychiatry Research (2024) Vol. 337, pp. 115926-115926
Closed Access | Times Cited: 2
Yuhua Hu, Hui Xue, Xiaoyan Ni, et al.
Psychiatry Research (2024) Vol. 337, pp. 115926-115926
Closed Access | Times Cited: 2
Discontinuation symptoms of antidepressants
Glyn Lewis, Gemma Lewis
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 485-486
Closed Access | Times Cited: 2
Glyn Lewis, Gemma Lewis
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 485-486
Closed Access | Times Cited: 2
Antidepressant discontinuation syndrome: A state-of-the-art clinical review
Michele Fornaro, C Cattaneo, Domenico De Berardis, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 1-10
Open Access | Times Cited: 12
Michele Fornaro, C Cattaneo, Domenico De Berardis, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 1-10
Open Access | Times Cited: 12
Outcomes of hyperbolic tapering of antidepressants
Jim van Os, Peter C. Groot
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 6
Jim van Os, Peter C. Groot
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 6
RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice
Katharine Wallis, Maria Donald, Mark Horowitz, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Katharine Wallis, Maria Donald, Mark Horowitz, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients in Australian primary care
Suzanne McDonald, Katharine Wallis, Mark Horowitz, et al.
British Journal of General Practice (2023) Vol. 74, Iss. 739, pp. e113-e119
Open Access | Times Cited: 3
Suzanne McDonald, Katharine Wallis, Mark Horowitz, et al.
British Journal of General Practice (2023) Vol. 74, Iss. 739, pp. e113-e119
Open Access | Times Cited: 3
Case report: Serotoninergic and cholinergic syndromes induced by self-medication
Sofía Orozco-Solano, Martha Milena Silva Castro, Manuel Machuca González
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Sofía Orozco-Solano, Martha Milena Silva Castro, Manuel Machuca González
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Understanding Australian general practice patients’ decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach
Amy Coe, Jane Gunn, Zoe Allnutt, et al.
BMJ Open (2024) Vol. 14, Iss. 2, pp. e078179-e078179
Open Access
Amy Coe, Jane Gunn, Zoe Allnutt, et al.
BMJ Open (2024) Vol. 14, Iss. 2, pp. e078179-e078179
Open Access